We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.81B
AUM Growth
+$209M
Cap. Flow
-$89.8M
Cap. Flow %
-1.55%
Top 10 Hldgs %
25.73%
Holding
880
New
85
Increased
289
Reduced
288
Closed
113

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$39.4M
2
SSNC icon
SS&C Technologies
SSNC
+$35.4M
3
XRAY icon
Dentsply Sirona
XRAY
+$34.3M
4
SCHW
Charles Schwab
SCHW
+$16.5M
5
ADI icon
Analog Devices
ADI
+$14.6M

Top Sells

Rank Stock Value
1
TSCO icon
Tractor Supply
TSCO
+$51.9M
2
BURL icon
Burlington
BURL
+$42.3M
3
CELG
Celgene Corp
CELG
+$38.2M
4
TMUS icon
T-Mobile US
TMUS
+$30.8M
5
MANH icon
Manhattan Associates
MANH
+$25.7M

Sector Composition

Rank Sector Weight
1 Financials 16.59%
2 Healthcare 16.26%
3 Technology 15.85%
4 Consumer Discretionary 12.33%
5 Communication Services 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
351
Parker-Hannifin
PH
$121B
$875K 0.02%
5,476
+38
+0.7% +$6.02K
VGK icon
352
Vanguard FTSE Europe ETF
VGK
$30.1B
$858K 0.01%
15,569
C icon
353
Citigroup
C
$223B
$857K 0.01%
12,816
+381
+3% +$23.4K
WY icon
354
Weyerhaeuser
WY
$17B
$857K 0.01%
25,568
-120
-0.5% -$4.04K
LOW icon
355
Lowe's Companies
LOW
$114B
$852K 0.01%
10,987
-225
-2% -$18.4K
AMAT icon
356
Applied Materials
AMAT
$448B
$851K 0.01%
20,598
-1,501
-7% -$63.8K
LAZ icon
357
Lazard
LAZ
$4.15B
$835K 0.01%
18,020
AIG icon
358
American International
AIG
$42.5B
$834K 0.01%
13,332
+8,964
+205% +$557K
LDL
359
DELISTED
Lydall, Inc.
LDL
$834K 0.01%
16,140
+617
+4% +$31.8K
STZ icon
360
Constellation Brands
STZ
$22.3B
$818K 0.01%
+4,224
New +$752K
AMLP icon
361
Alerian MLP ETF
AMLP
$12.8B
$817K 0.01%
13,657
-299
-2% -$18.2K
DUK icon
362
Duke Energy
DUK
$98.2B
$816K 0.01%
9,761
GWW icon
363
W.W. Grainger
GWW
$64.7B
$815K 0.01%
4,517
+239
+6% +$45.1K
DOOR
364
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$815K 0.01%
+10,800
New +$829K
KSU
365
DELISTED
Kansas City Southern
KSU
$813K 0.01%
+7,768
New +$728K
IWR icon
366
iShares Russell Mid-Cap ETF
IWR
$56.8B
$800K 0.01%
16,652
+1,004
+6% +$47.6K
CDK
367
DELISTED
CDK Global, Inc.
CDK
$798K 0.01%
12,854
+9,454
+278% +$593K
EPR icon
368
EPR Properties
EPR
$4.76B
$797K 0.01%
+11,095
New +$808K
PSX icon
369
Phillips 66
PSX
$85.1B
$781K 0.01%
9,443
AMTD
370
DELISTED
TD Ameritrade Holding Corp
AMTD
$780K 0.01%
18,150
-1,255
-6% -$48.7K
WWD icon
371
Woodward
WWD
$23.3B
$778K 0.01%
11,516
+373
+3% +$25.4K
BAX icon
372
Baxter International
BAX
$11.4B
$774K 0.01%
12,792
-2,362
-16% -$134K
LAUR icon
373
Laureate Education
LAUR
$5.05B
$763K 0.01%
+43,525
New +$689K
MBLY
374
DELISTED
Mobileye N.V.
MBLY
$763K 0.01%
+12,142
New +$753K
HOLX
375
DELISTED
Hologic
HOLX
$759K 0.01%
16,728
-2,750
-14% -$121K

Similar funds

Geneva Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Geneva Advisors held 880 positions worth $5.81B, up 3.7% from $5.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Geneva Advisors's Q2 2017 filing shows 85 new, 289 increased, 288 reduced and 113 closed positions. Its largest new stake was Golub Capital BDC: 98,783 shares worth $1.85M. The largest sale was Tractor Supply, an estimated $51.9M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • Geneva Advisors's largest Q2 2017 buy was Golub Capital BDC: 98,783 shares worth $1.85M.
  • Geneva Advisors added most to CME Group in Q2 2017, an estimated $39.4M increase.
  • Geneva Advisors's biggest Q2 2017 reduction was Tractor Supply, cutting an estimated $51.9M.
  • Geneva Advisors fully exited Syneos Health, Inc. Class A Common Stock in Q2 2017, selling an estimated $11.3M.
  • Geneva Advisors's ten largest holdings make up 26% of its $5.81B portfolio in Q2 2017.
  • Geneva Advisors opened 85 new positions and closed 113 in Q2 2017.
  • Geneva Advisors's portfolio value rose 3.7% quarter-over-quarter to $5.81B.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.